白细胞介素-18在成人斯蒂尔病中：治疗靶点还是疾病活动指标？ - Suppr | 超能文献

Interleukin-18 in adult-onset Still's disease: treatment target or disease activity indicator?

作者信息

Nagashima Takao, Iwamoto Masahiro, Matsumoto Kazuko, Minota Seiji

出版信息

Intern Med. 2012;51(4):449; author reply 451. doi: 10.2169/internalmedicine.51.6678. Epub 2012 Feb 15.

DOI:10.2169/internalmedicine.51.6678

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Interleukin-18 in adult-onset Still's disease: treatment target or disease activity indicator?白细胞介素-18在成人斯蒂尔病中：治疗靶点还是疾病活动指标？

Intern Med. 2012;51(4):449; author reply 451. doi: 10.2169/internalmedicine.51.6678. Epub 2012 Feb 15.

2

Tocilizumab improved both clinical and laboratory manifestations except for interleukin-18 in a case of multiple drug-resistant adult-onset Still's disease.在一例多药耐药的成人斯蒂尔病患者中，托珠单抗改善了除白细胞介素-18之外的临床和实验室指标表现。

Intern Med. 2011;50(16):1757-60. doi: 10.2169/internalmedicine.50.4771. Epub 2011 Aug 15.

3

Efficacy of canakinumab as first-line biologic agent in adult-onset Still's disease.卡那单抗作为成人斯蒂尔病一线生物制剂的疗效。

Arthritis Res Ther. 2019 Feb 13;21(1):54. doi: 10.1186/s13075-019-1843-9.

4

A case of refractory adult-onset Still's disease with high serum interleukin-18 levels treated with monitoring of serum levels of cyclosporine.1例难治性成人斯蒂尔病伴血清白细胞介素-18水平升高患者，采用监测环孢素血药浓度的方法进行治疗。

Fukuoka Igaku Zasshi. 2012 Jan;103(1):24-8.

5

Biomarkers for disease flare in patients with adult-onset Still's disease undergoing treatment with tocilizumab.接受托珠单抗治疗的成人斯蒂尔病患者疾病复发的生物标志物。

Rheumatology (Oxford). 2020 Feb 1;59(2):440-442. doi: 10.1093/rheumatology/kez392.

6

Interleukin-18 as a diagnostic marker of adult-onset Still's disease in older patients: a case report and review of the literature.白细胞介素-18作为老年成人斯蒂尔病的诊断标志物：一例病例报告及文献复习

J Med Case Rep. 2018 Jul 10;12(1):198. doi: 10.1186/s13256-018-1735-7.

7

A Japanese case of severe refractory adult Still's disease: serum interleukin-18 is a possible marker of the response to low-dose cyclosporin A therapy.一例日本成人严重难治性斯蒂尔病病例：血清白细胞介素-18可能是低剂量环孢素A治疗反应的标志物。

Fukuoka Igaku Zasshi. 2002 Sep;93(9):189-95.

8

Prolonged treatment with Tadekinig alfa in adult-onset Still's disease.用他克莫司α治疗成人斯蒂尔病的长期疗效。

Ann Rheum Dis. 2020 Jan;79(1):e10. doi: 10.1136/annrheumdis-2018-214496. Epub 2018 Oct 23.

9

Interleukin-18 as a novel diagnostic marker and indicator of disease severity in adult-onset Still's disease.白细胞介素-18作为成人斯蒂尔病的一种新型诊断标志物和疾病严重程度指标。

Arthritis Rheum. 2001 Jul;44(7):1716-7. doi: 10.1002/1529-0131(200107)44:7<1716::AID-ART298>3.0.CO;2-I.

10

[Tocilizumab effectiveness in adult Still's disease].托珠单抗在成人斯蒂尔病中的疗效

Med Clin (Barc). 2012 Jan 21;138(1):42-3. doi: 10.1016/j.medcli.2011.04.002. Epub 2011 May 24.

引用本文的文献

1

Treatment of adult-onset Still's disease: a review.成人斯蒂尔病的治疗：综述。

Ther Clin Risk Manag. 2014 Dec 22;11:33-43. doi: 10.2147/TCRM.S64951. eCollection 2015.

2

Interleukin 1 inhibition with anakinra in adult-onset Still disease: a meta-analysis of its efficacy and safety.阿那白滞素对成人斯蒂尔病白细胞介素1的抑制作用：疗效与安全性的荟萃分析

Drug Des Devel Ther. 2014 Nov 25;8:2345-57. doi: 10.2147/DDDT.S73428. eCollection 2014.